title: Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.
abstract: Dexamethasone, a synthetic corticosteroid, is widely used as a potent anti-inflammatory drug in various diseases including corneal angiogenesis. However, dexamethasone's impact on interleukin (IL)-1beta-dependent inflammatory angiogenesis is unknown. Here, we show that dexamethasone inhibits IL-1beta-induced neovascularization and the expression of the angiogenesis-related factors, vascular endothelial growth factor-A, KC, and prostaglandin E(2) in the mouse cornea 2 days after IL-1beta implantation. IL-1beta caused IkappaB-alpha phosphorylation in corneal stromal cells but not in infiltrated CD11b(+) cells 2 days after IL-1beta implantation. In contrast, both cell types were positive for phosphorylated IkappaB-alpha 4 days after IL-1beta implantation. Dexamethasone significantly inhibited IkappaB-alpha phosphorylation 2 and 4 days after IL-1beta implantation. Furthermore, dexamethasone inhibited IL-1beta-induced expression of vascular endothelial growth factor-A, KC, and prostaglandin E(2), and signaling of nuclear factor (NF)-kappaB in corneal fibroblasts in vitro. A selective NF-kappaB inhibitor attenuated IL-1beta-induced corneal angiogenesis. These findings suggest that NF-kappaB activation in the corneal stromal cells is an important early event during IL-1beta-induced corneal angiogenesis and that dexamethasone inhibits IL-1beta-induced angiogenesis partially via blocking NF-kappaB signaling.
authors: Department of Ophthalmology, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka 812-8582, Japan.
authors: Shintaro
authors: S
authors: Nakao
authors: Yasuaki
authors: Y
authors: Hata
authors: Muneki
authors: M
authors: Miura
authors: Kousuke
authors: K
authors: Noda
authors: Yusuke N
authors: YN
authors: Kimura
authors: Shuhei
authors: S
authors: Kawahara
authors: Takeshi
authors: T
authors: Kita
authors: Toshio
authors: T
authors: Hisatomi
authors: Toru
authors: T
authors: Nakazawa
authors: Yiping
authors: Y
authors: Jin
authors: M Reza
authors: MR
authors: Dana
authors: Michihiko
authors: M
authors: Kuwano
authors: Mayumi
authors: M
authors: Ono
authors: Tatsuro
authors: T
authors: Ishibashi
authors: Ali
authors: A
authors: Hafezi-Moghadam
mesh_terms: D000818:Animals; D039481:CD11b Antigen / Q000378:metabolism; D002478:Cells, Cultured; D003315:Cornea / Q000098:blood supply* / Q000166:cytology / Q000502:physiology; D016510:Corneal Neovascularization / Q000276:immunology*; D003907:Dexamethasone / Q000378:metabolism*; D005938:Glucocorticoids / Q000378:metabolism*; D053583:Interleukin-1beta / Q000378:metabolism*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000378:metabolism*; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism*
chemical_list: D039481:CD11b Antigen; D005938:Glucocorticoids; D053583:Interleukin-1beta; D016328:NF-kappa B; D003907:Dexamethasone
references: Int J Biochem Cell Biol. 2006;38(10):1625-31
references: 16675284
references: Biochem Pharmacol. 2006 Oct 30;72(9):1054-68
references: 16973133
references: Mol Vis. 2001 May 8;7:107-13
references: 11344338
references: Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2892-7
references: 10549649
references: J Immunol. 2000 Nov 1;165(9):4927-34
references: 11046018
references: J Immunol. 2000 Nov 1;165(9):5269-77
references: 11046061
references: Prog Retin Eye Res. 2001 Sep;20(5):625-37
references: 11470453
references: Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2795-803
references: 11687520
references: Nat Med. 2002 May;8(5):473-9
references: 11984591
references: J Immunol. 2002 Jul 1;169(1):469-75
references: 12077278
references: Mol Vis. 2003 Apr 2;9:96-102
references: 12677165
references: FASEB J. 2004 Feb;18(2):300-10
references: 14769824
references: J Immunol. 2004 Mar 15;172(6):3736-44
references: 15004178
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11658-63
references: 15289610
references: Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2998-3004
references: 15326113
references: Am J Ophthalmol. 1978 Sep;86(3):418-23
references: 717508
references: Proc Natl Acad Sci U S A. 1981 Feb;78(2):1176-80
references: 6262756
references: J Cell Physiol. 1982 Nov;113(2):197-202
references: 6217211
references: Arch Ophthalmol. 1985 May;103(5):708-11
references: 2581536
references: Ann Surg. 1987 Sep;206(3):374-83
references: 2443088
references: Arch Ophthalmol. 1990 Apr;108(4):573-6
references: 1690981
references: Ophthalmology. 1993 Jan;100(1):9-14
references: 7679482
references: J Immunol. 1993 Jul 1;151(1):277-83
references: 8392096
references: Cornea. 1994 Jan;13(1):4-8
references: 8131405
references: Exp Eye Res. 1993 Dec;57(6):693-8
references: 7512045
references: Blood. 1996 Mar 15;87(6):2095-147
references: 8630372
references: Arch Ophthalmol. 1996 Aug;114(8):1000-1
references: 8694704
references: Jpn J Ophthalmol. 1997 Mar-Apr;41(2):63-6
references: 9152805
references: Cornea. 1998 Jul;17(4):403-9
references: 9676913
references: Cancer Res. 1999 Oct 1;59(19):5002-11
references: 10519415
references: Nat Rev Cancer. 2004 Nov;4(11):839-49
references: 15516957
references: Invest Ophthalmol Vis Sci. 2005 Feb;46(2):497-503
references: 15671274
references: Cytokine Growth Factor Rev. 2005 Feb;16(1):77-89
references: 15733833
references: Am J Pathol. 2005 May;166(5):1393-403
references: 15855640
references: Cell. 2005 May 6;121(3):335-48
references: 15882617
references: Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2346-52
references: 15980221
references: J Virol. 2005 Aug;79(16):10589-600
references: 16051851
references: Cornea. 2005 Nov;24(8 Suppl):S2-S11
references: 16227819
references: N Engl J Med. 2005 Oct 20;353(16):1711-23
references: 16236742
references: J Clin Invest. 2005 Nov;115(11):2979-91
references: 16239969
references: Eur J Cancer. 2006 Apr;42(6):768-78
references: 16510280
references: Cancer Res. 2006 May 15;66(10):5346-53
references: 16707461